Showing results (1-10 of 341) with videos related to
Sort By:
Pageof 35
Journal of Immunology (Baltimore, Md. : 1950)|May 18, 2012
B cell receptor-ERK1/2 signal cancels PAX5-dependent repression of BLIMP1 through PAX5 phosphorylation: a mechanism of antigen-triggering plasma cell differentiationTakahiko Yasuda, Fumihiko Hayakawa, Shingo Kurahashi, et al.Leukemia Research Reports|December 28, 2013
GATA2 zinc finger 2 mutation found in acute myeloid leukemia impairs myeloid differentiationKeiko Niimi, Hitoshi Kiyoi, Yuichi Ishikawa, et al.The Journal of Biological Chemistry|December 26, 2015
B Cell Linker Protein (BLNK) Is a Selective Target of Repression by PAX5-PML Protein in the Differentiation Block That Leads to the Development of Acute Lymphoblastic LeukemiaNaoto Imoto, Fumihiko Hayakawa, Shingo Kurahashi, et al.American Journal of Hematology|April 2, 2009
Combinations of cytogenetics and international scoring system can predict poor prognosis in multiple myeloma after high-dose chemotherapy and autologous stem cell transplantationYoshihiro Inamoto, Shingo Kurahashi, Nobuhiko Imahashi, et al.Nagoya Journal of Medical Science|June 26, 2020
＜Editors' Choice＞ How to improve outcomes of elderly patients with acute myeloid leukemia: era of excitementTomoki NaoeCurrent Pharmaceutical Biotechnology|November 2, 2006
Developing target therapy against oncogenic tyrosine kinase in myeloid maliganaciesTomoki NaoeGan to Kagaku Ryoho. Cancer & Chemotherapy|April 22, 2009
[Circumventing resistance to imatinib therapy in chronic myeloid leukemia]Yosuke Minami, Tomoki NaoeInternational Journal of Hematology|January 30, 2013
Gene mutations of acute myeloid leukemia in the genome eraTomoki Naoe, Hitoshi KiyoiLeukemia & Lymphoma|October 29, 2002
FLT3 in human hematologic malignanciesHitoshi Kiyoi, Tomoki NaoeLeukemia & Lymphoma|October 27, 2006
Imatinib combined chemotherapy for Philadelphia chromosome-positive acute lymphoblastic leukemia: major challenges in current practiceMasamitsu Yanada, Tomoki NaoePageof 35